Tag Archives: biopharmaceuticals

Shrinking Economy Hits California Biosector

By Guest Blogger | Published: February 10, 2012
By Amy Ritter, Pharmaeutical Technology. A report released on Feb. 8, 2012 from the California Healthcare Institute, BayBio and PwC shows that the shrinking economy, changes in investment strategies, and pressures on the pharmaceutical market have put the brakes on one of the US’s most robust biotechnology centers. California had enjoyed steady growth in its biotech [...]
Posted in Biotech, Guest Blog | Also tagged , , , | Leave a comment

California Biotech — Good Governance Tops Wish List

By William Looney | Published: February 2, 2011
New industry survey data documents a fraying investment base marked by a distant and unresponsive FDA as well as an unprepared work force complacent about hungry foreign competition. California’s biotech industry has taken its annual pulse of business conditions — and while the prognosis is not for putting the state on the policy equivalent of life [...]
Posted in Biotech, FDA, R&D, Strategy, healthcare | Also tagged , , , , | Leave a comment

Fixing Biotech's Broken Business Model

By Julian Upton | Published: December 22, 2010
Despite some notable successes, the global biotech industry has fallen short of expectations. Strategic collaborations have been on the increase, but there is now a need for more co-operation using new collaboration models, writes Jo Pisani. The current business model on which biotech has relied is flawed. Due to poor rates of return, investment has dried [...]
Posted in Biotech, Deals, Emerging Markets, Europe, Global, Guest Blog, R&D | Also tagged , , , , , , , | Leave a comment

Reaching 'the Customer': A Q&A with Sheri Dodd

By William Looney | Published: November 3, 2010
As a unique mix of payers, providers, patients and industry executives prepare to convene for CBI’s first Commercialization and Market Access Congress in Orlando next month, Pharm Exec editor-in-chief William Looney sits down with Congress co-chair Sheri Dodd of Medtronic to review key themes and trends likely to dominate the two days of discussion. [...]
Posted in Market Access, Strategy | Also tagged , | Leave a comment